{
    "id": "tuberculosis_medications_education_selectAll_v1",
    "type": "selectAll",
    "stem": "The nurse is providing discharge education for a client starting multidrug therapy for active pulmonary tuberculosis (TB) with Isoniazid, Rifampin, Ethambutol, and Pyrazinamide. Which information should the nurse include?",
    "options": [
        {
            "id": "b",
            "text": "Expect your urine, sweat, and tears to turn a harmless orange-red color."
        },
        {
            "id": "d",
            "text": "You may stop the medication once your sputum cultures are negative."
        },
        {
            "id": "c",
            "text": "Contact the provider if you experience any changes in your vision or color perception."
        },
        {
            "id": "a",
            "text": "Report any new yellowing of the eyes or skin (jaundice) immediately."
        },
        {
            "id": "e",
            "text": "Avoid drinking alcohol for the duration of the entire treatment course."
        },
        {
            "id": "f",
            "text": "Take a Vitamin B6 (pyridoxine) supplement daily as prescribed."
        }
    ],
    "correctOptionIds": [
        "a",
        "b",
        "c",
        "e",
        "f"
    ],
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Pharmacology",
            "Infectious Disease",
            "Tuberculosis"
        ]
    },
    "rationale": {
        "correct": "TB therapy is complex and high-risk. (A) Isoniazid, Rifampin, and Pyrazinamide are all hepatotoxic; jaundice is a sign of liver failure. (B) Rifampin causes orange discoloration of body fluids. (C) Ethambutol can cause optic neuritis (vision/color changes). (E) Alcohol increases the risk of severe drug-induced hepatitis. (F) Vitamin B6 prevents peripheral neuropathy caused by Isoniazid.",
        "incorrect": "(D) TB treatment must continue for the full duration (6-12 months) even if the client feels better or has negative cultures to prevent drug resistance; stopping early is the #1 cause of treatment failure.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "The inclusion of \"Expect your urine, sweat, and tears to turn a harmless orange-red color.\" is necessary to address the underlying physiological instability identified during assessment.",
                "isCorrect": true
            },
            {
                "label": "B",
                "content": "Selecting \"You may stop the medication once your sputum cultures are negative.\" might delay more critical interventions, as it does not address the immediate life-threatening risk.",
                "isCorrect": false
            },
            {
                "label": "C",
                "content": "Clinically, \"Contact the provider if you experience any changes in your vision or color perception.\" is the most appropriate finding pointing toward the suspected condition and requiring intervention.",
                "isCorrect": true
            },
            {
                "label": "D",
                "content": "\"Report any new yellowing of the eyes or skin (jaundice) immediately.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "E",
                "content": "The inclusion of \"Avoid drinking alcohol for the duration of the entire treatment course.\" is necessary to address the underlying physiological instability identified during assessment.",
                "isCorrect": true
            },
            {
                "label": "F",
                "content": "Selecting \"Take a Vitamin B6 (pyridoxine) supplement daily as prescribed.\" is evidence-based as it directly correlates with the primary clinical cues and pathophysiology.",
                "isCorrect": true
            }
        ],
        "clinicalPearls": [
            "Directly Observed Therapy (DOT) is the preferred method to ensure adherence and prevent multi-drug resistant TB (MDR-TB)."
        ],
        "questionTrap": {
            "trap": "The 'Negative Culture' Misconception",
            "howToOvercome": "Never choose an option that allows a patient to stop antibiotics or TB meds 'when they feel better' or 'when cultures are clear' before the prescribed date."
        },
        "mnemonic": {
            "title": "R-I-P-E",
            "expansion": "Rifampin (Red/orange), Isoniazid (INH/Neuropathy/B6), Pyrazinamide (Pseudo-gout/Uric acid), Ethambutol (Eyes/Optic neuritis)."
        },
        "reviewUnits": [
            {
                "heading": "Anti-Tubercular Pharmacotherapy",
                "body": "Nurses must monitor LFTs regularly. Education focuses on adherence, side effect recognition (Eyes, Nerves, Liver), and the non-infectious transition (after 2-3 weeks of therapy and clinical improvement).",
                "source": "CDC TB treatment guidelines 2026"
            }
        ]
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    }
}